The Challenge of Fungal Infections in AML



In this segment, Kieren A. Marr, MD, professor of medicine in the Johns Hopkins School of Medicine, professor of oncology in the Sidney Kimmel Comprehensive Cancer Center, and medical director of the Transplant and Oncology Infectious Diseases program at Hopkins, emphasizes the importance of prevention of fungal infections, as they provide many challenges in managing and treating acute myeloid leukemia (AML).

The prevalence of breakthrough fungal infections is high in individuals who are not receiving any therapy to prevent it, especially in those with prolonged neutropenia and breakdown of the gastrointestinal (GI) tract. The infections can occur as a result of the overgrowth of organisms already present in the GI tract, such as candida, according to Kieren A. Marr, MD. For example, chronic candidiasis can develop when those invasive organisms escape into the bloodstream or the portal vascular. In addition, patients who have suppressed secondary responses because of persistent neutropenia are at risk for invasive pulmonary fungal infections, such as aspergillosis.

One of the problems with determining an accurate prevalence of these fungal infections is the lack of diagnostics, especially in infections involving the lungs, states Marr. Establishing the diagnosis is challenging because the organisms do not grow rapidly from the blood or lungs. However, diagnosing fungal infections has improved over the past 10 years.

The underlying morbidity associated with treating AML also adds to the complexity of diagnosing invasive fungal infections. For example, gut mucositis that can occur with AML can lead to false-positive tests on the antigen-based assays.

Related Videos
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
© 2024 MJH Life Sciences

All rights reserved.